HCV NS3 PROTEASE INHIBITORS
The present invention relates to macrocyclic compounds of formula (Ia) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Korean |
Published |
19.10.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to macrocyclic compounds of formula (Ia) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. |
---|---|
Bibliography: | Application Number: KR20117016721 |